Origin Life Sciences, Inc. — Form D

Origin Life Sciences, Inc. of PRINCETON, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2023-10-17. The offering totals $5.0M, of which $51K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (21)

NameRoleLocation
Anthony David BramptonDirectorPrinceton, NJ
David David DantzkerDirectorPrinceton, NJ
Jerome Boda KortenDirectorPrinceton, NJ
Victor David MicatiDirectorPrinceton, NJ
Michael David PrestonDirectorPrinceton, NJ
David David DantzkerExecutive OfficerPrinceton, NJ
John David FernandesExecutive OfficerPrinceton, NJ
Michael David PrestonExecutive OfficerPrinceton, NJ
Alex David Dolgopolsky, PhDExecutive OfficerPrinceton, NJ
Howard David NelsonDirectorPrinceton, NJ
Howard David NelsonExecutive OfficerPrinceton, NJ
Tony David BramptonDirectorPrinceton, NJ
Johnny David FernandesExecutive OfficerPrinceton, NJ
Vic David MicatiDirectorPrinceton, NJ
Mike David PohlExecutive OfficerPrinceton, NJ
David David Dantzker, MDDirectorPrinceton, NJ
David David Dantzker, MDExecutive OfficerPrinceton, NJ
Betsy David HannaExecutive OfficerPrinceton, NJ
Michael David PohlExecutive OfficerLawrenceville, NJ
Alex David Dolgopolsky, MDExecutive OfficerLawrenceville, NJ
Issac David Anthony IIIExecutive OfficerLawrenceville, NJ

Other filings by this issuer (5)

FiledFormOfferingSold
2023-06-22D/A$850K$660K
2023-06-01D$850K$500K
2022-09-07D$5.0M$500K
2017-05-15D$22.5M$1.3M
2013-04-08D$2.5M$500K

More